Smoking Cessation in a Cohort HIV+ Rio de Janeiro, Brazil.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

115 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-10

Study Completion Date

2023-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was carried out within a large, urban prospective cohort of PLHIV at the Instituto Nacional de Infectologia Evandro Chagas (INI). Located in Rio de Janeiro, Brazil, INI is a national public referral center for PLWHA receiving primary care since 1998. From December 2019, adults who had attitudes toward quitting smoking and had no contraindications to study pharmacotherapy were enrolled by active site searching

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

NCT02836067

HIV Smoking

COMPLETED NA

Facilitating Smoking Cessation With Reduced Nicotine Cigarettes

NCT02796391

Smoking Cessation

COMPLETED PHASE2

Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil

NCT05560243

HIV Infections Tobacco Use Cessation

COMPLETED NA

Motivation and Patch Treatment for HIV-positive Smokers

NCT00551720

HIV Infections Smoking Cessation

COMPLETED PHASE3

Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya

NCT06790342

HIV Tobacco Use Alcohol Use Disorder

NOT_YET_RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation Brachial Flow Mediated Dilatation Nicotine Replacement Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Relapse

Nicotine replacement

Intervention Type DRUG

Nicotine patches

Group 2

Smoking cessation

Nicotine replacement

Intervention Type DRUG

Nicotine patches

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nicotine replacement

Nicotine patches

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* individuals were deemed as regular smokers, defined as the consumption of one or more pack (20 cigarettes) per week in the past 6 months, and expired carbon monoxide (CO) measurement \> 10 ppm at the screening visit.

Exclusion Criteria

* previous use of transdermal nicotine patches or bupropion in the last 6 months; (ii) contraindication to nicotine patches; (iii). Pregnancy; (iv) breastfeeding

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes